Spasticity
120 results
1 - 100
Spasticity 
Anti‐spasticity agents for multiple sclerosis- Anti-spasticity agents for multiple sclerosis
- Pharmacological interventions for spasticity following spinal cord injury
- Non-pharmacological interventions for spasticity in multiple sclerosis
- Interventions for managing skeletal muscle spasticity following traumatic brain injury
- Intrathecal baclofen for treating spasticity in children with cerebral palsy
- Pharmacological interventions other than botulinum toxin for spasticity after stroke
- Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease
- Non pharmacological interventions for spasticity in multiple sclerosis: Cochrane systematic review
- Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease
- Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity: Cochrane systematic review
- Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy
Cannabinoids somewhat helpful for nausea, maybe helpful for spasticity, probably not helpful for non-neuropathic pain- Moderate or better evidence for specific cannabinoids for chronic pain, Tourette, epilepsy, spasticity, sleep, Parkinson, and other conditions
- Botulinum toxin type A in the treatment of limb spasticity in children with cerebral palsy
- Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
- Muscle weakness and paralysis symptom
- Passive movements for the treatment and prevention of contractures: Cochrane systematic review
- Rehabilitation of patients with spinal cord injury, and problems associated with such injury
- Medical marijuana for various neurologic conditions: mixed outcomes
- Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease
- Amyotrophic lateral sclerosis (ALS)
- Neurological examination
- Botulinum toxin for shoulder pain
- Multiple sclerosis (MS)
- Diseases of the spinal cord
- Medical cannabis use not supported by a wealth of research
- Frontotemporal lobar degeneration
- Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE): Cochrane systematic review
- Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke
- Constraint‐induced movement therapy for upper extremities in people with stroke
- Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease
- Transcranial magnetic stimulation = sham TMS for motor recovery after stroke (NICHE)
- Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews
- Lumbar spinal stenosis (LSS)
- No benefit, longer hospital stay with treatment of asymptomatic bacteriuria
- Surgery for cervical radiculopathy or myelopathy: Cochrane systematic review
- Peripheral neuropathies: examination of the patient
- Steroid doping
- Drugs used in alcohol dependence
- Constraint-induced movement therapy for upper extremities in stroke patients
- Fluid therapy for acute bacterial meningitis
- Acute psychosis
- Stretch for the treatment and prevention of contractures
- Rehabilitation of a patient with cerebrovascular disorder
- Acute treatment of traumatic spinal cord injuries
- Electrical stimulation for preventing and treating post‐stroke shoulder pain
- Trihexyphenidyl for dystonia in cerebral palsy